Pharmaceutical Excipients Market Size, Share, Growth and Industry Analysis, By Types (Organic Chemicals, Inorganic Chemicals, Others), By Applications (Pharmaceuticals Companies, Research Organization, Academics, Others), Regional Insights and Forecast to 2035
Buy Now 
Pharmaceutical Excipients Market Size
The Pharmaceutical Excipients Market was valued at USD 11.11 billion in 2025 and expanded to USD 11.89 billion in 2026. The market is expected to maintain consistent growth, reaching USD 12.73 billion in 2027, and is projected to attain USD 21.98 billion by 2035. During the projected revenue period from 2026 to 2035, the market is anticipated to grow at a CAGR of 7.06%, driven by increasing pharmaceutical manufacturing activities, rising demand for advanced drug formulations, and growing adoption of high-performance excipients in solid, liquid, and biologic dosage forms. Continuous innovation in multifunctional excipients and the expansion of generic and specialty drug production are further supporting sustained market growth worldwide.
The U.S. pharmaceutical excipients market holds a significant share, driven by advanced pharmaceutical manufacturing, high healthcare spending, and strong regulatory support. It is poised for continued growth, contributing approximately 35% of the global market share.
The pharmaceutical excipients market is essential for ensuring the stability and effectiveness of pharmaceutical formulations. Cellulose derivatives dominate the market, contributing approximately 30% due to their versatility in various dosage forms. Starch derivatives account for around 25%, frequently used as binders and disintegrants in tablets. Inorganic salts represent 20% of the market, particularly in injectable and liquid formulations, while medicinal sucrose holds about 15%, often utilized in oral syrups and solutions. The remaining 10% consists of other excipients like lipids and proteins, especially in biologics and novel drug delivery systems. Regional insights reveal 35% of the market share in North America, 25% in Europe, and 20% in the Asia-Pacific region, with the remaining 20% spread across other regions.
Pharmaceutical Excipients Market Trends
The pharmaceutical excipients market has shown impressive diversity in its growth across various segments and regions. The demand for excipients has expanded rapidly with the increased prevalence of chronic diseases and an aging global population, pushing pharmaceutical companies to develop innovative drugs. In recent years, cellulose derivatives have dominated the market due to their versatility and ability to improve drug formulations. For example, cellulose and its derivatives are extensively used in solid oral dosage forms, such as tablets and capsules, thanks to their high solubility, stability, and low toxicity. Similarly, starch derivatives have found widespread application in formulating high-quality drugs, owing to their natural origin and ease of modification.
Pharmaceutical Excipients Market Dynamics
The dynamics of the pharmaceutical excipients market are influenced by various factors, including demand for more effective and safer drug formulations, innovations in drug delivery systems, and regulatory developments. The increasing focus on personalized medicine has also triggered a shift in the types of excipients used, pushing pharmaceutical companies to prioritize excipient functionality. The formulation stability excipients segment is a major growth area, as the demand for improved drug stability remains a priority for pharmaceutical manufacturers. Notably, excipients for solid preparation drugs contribute significantly to market demand, accounting for nearly 40% of the total excipient usage globally.
DRIVER
"Rising demand for pharmaceuticals"
One of the key drivers of growth in the pharmaceutical excipients market is the increasing demand for pharmaceuticals across the globe. As healthcare needs rise due to an aging population and the increasing prevalence of chronic diseases, the need for more effective drug formulations is also escalating. In particular, the global pharmaceutical industry is expanding in both developed and emerging markets, with the Asia Pacific region projected to witness a growth of 25%. The rise in chronic conditions like diabetes, cardiovascular diseases, and cancer is driving this demand. Furthermore, the growth in biopharmaceuticals and biologics is contributing to an increased need for excipients tailored to these complex drug formulations.
RESTRAINT
"Regulatory Challenges and Compliance"
The pharmaceutical excipients market faces several regulatory challenges, particularly regarding the safety and quality standards imposed by governing bodies. Regulatory authorities like the FDA and EMA have stringent guidelines on the use and approval of excipients in drug formulations. Non-compliance with these standards can lead to significant delays in product launches and increased costs for manufacturers. Approximately 20% of pharmaceutical companies report that meeting regulatory requirements is one of the biggest hurdles in excipient development. These regulations are not only time-consuming but also expensive to navigate, as manufacturers must invest in constant testing and validation.
OPPORTUNITY
"Growth in Personalized Medicines"
The rapid advancement of personalized medicine presents significant opportunities for the pharmaceutical excipients market. As more drugs are tailored to individual genetic profiles, there is a rising need for excipients that enhance the effectiveness and safety of these treatments. Personalized medicine is gaining popularity, with the global market for personalized treatments growing by over 15%. Excipients that provide optimal drug delivery and compatibility with biologics are crucial in this evolving landscape. Additionally, advancements in drug formulation techniques, such as controlled-release and targeted delivery systems, offer exciting opportunities for excipient manufacturers to provide innovative solutions.
CHALLENGE
"Rising Manufacturing Costs"
The rising costs associated with pharmaceutical manufacturing are a significant challenge for the excipients market. With stringent quality control measures, the cost of producing excipients has been increasing, especially for those used in biopharmaceuticals and biologic drugs. Approximately 25% of pharmaceutical manufacturers report that the rising cost of raw materials and production equipment is one of their primary concerns. The need for high-quality, safe excipients for complex drug formulations adds further to these production costs. Additionally, economic pressures and competition in the pharmaceutical industry may lead to price reductions, making it difficult for excipient manufacturers to maintain profitability.
Segmentation Analysis
The pharmaceutical excipients market is increasingly segmented into various types and applications, catering to the growing demand for specialized formulations. Cellulose and derivatives dominate the market, accounting for 30%, due to their widespread use as binders, fillers, and stabilizers in tablet formulations. Starch and derivatives follow closely, holding about 25% of the market share, especially in solid dosage forms. Inorganic salts make up approximately 20%, often used as buffers and stabilizers in liquid formulations. Medicinal sucrose holds around 15%, primarily used in syrups and solutions. The remaining 10% is captured by other excipients, including natural polymers and advanced materials for biologics.
By Type
- Cellulose and Derivatives: Cellulose and its derivatives are among the most widely used excipients in the pharmaceutical industry, accounting for a significant portion of the global market. This category includes types like microcrystalline cellulose, carboxymethyl cellulose, and hydroxypropyl methylcellulose, which are primarily used as binders, stabilizers, and fillers in tablet and capsule formulations. With their excellent solubility, safety profile, and biodegradability, cellulose derivatives represent over 35% of the excipients market.
- Starch and Derivatives: Starch and its derivatives are another crucial excipient type in pharmaceutical formulations. Starch, along with modified starches like pre-gelatinized starch, is used as a binder, disintegrant, and filler. The segment is growing in demand due to its natural origin and suitability for use in both solid and semi-solid formulations. Starch derivatives, such as hydroxypropyl starch, are particularly valued for their ability to improve the solubility and stability of poorly water-soluble drugs. This segment contributes approximately 25% to the global pharmaceutical excipients market, with its growth supported by a shift toward more natural and cost-effective excipient materials.
- Inorganic Salts: Inorganic salts, including magnesium stearate and sodium chloride, are essential excipients for pharmaceutical manufacturing, contributing around 15% of the global market share. Magnesium stearate, used primarily as a lubricant in tablet formulations, ensures the smooth operation of tablet compression machines, preventing sticking and enhancing the uniformity of dosage forms. Sodium chloride and other inorganic salts are vital for enhancing the solubility of poorly soluble drugs. The demand for inorganic salts is increasing due to the growth of solid dosage formulations, with magnesium stearate being a dominant player in the market. These excipients are crucial for improving the overall quality and stability of pharmaceutical products.
- Medicinal Sucrose: Medicinal sucrose is a commonly used excipient in the pharmaceutical industry, particularly for oral formulations like syrups, tablets, and lozenges. Sucrose serves as a sweetening agent, stabilizer, and excipient for controlled-release formulations. It is crucial in formulations targeting pediatric and geriatric populations, where taste masking is important. Medicinal sucrose holds around 10% of the excipients market share and continues to grow as demand for liquid oral dosage forms rises. Its role in improving patient compliance, especially in children's medications, positions it as an important excipient for pharmaceutical companies looking to improve patient satisfaction and the effectiveness of oral drug delivery.
- Other Excipients: The Other excipients category includes a wide range of materials, such as oils, alcohols, proteins, and gums, which are used across different drug formulations. This segment accounts for roughly 15% of the pharmaceutical excipients market. These excipients are often used for specialized purposes, such as in the formulation of vaccines, biologics, and injectables. With the growing focus on advanced drug delivery systems and biologics, the demand for specialized excipients in this category is expected to grow. The rise in biologic drugs and gene therapies is expected to drive this segment further, contributing to the development of innovative and effective pharmaceutical products.
By Application
- Formulation Stability Excipients: Formulation stability excipients are critical in maintaining the integrity of pharmaceutical formulations over time, contributing significantly to the excipient market. This application holds a dominant share, accounting for approximately 40% of the market. These excipients, including antioxidants, preservatives, and stabilizers, help protect drugs from degradation caused by light, temperature, and moisture. With the increasing demand for biologics and injectables, which require enhanced stability, formulation stability excipients are increasingly sought after. Their role in ensuring the efficacy and shelf life of drugs makes them indispensable in drug formulation processes, particularly for high-value biologics and specialty pharmaceuticals.
- Solid Preparation Excipients: Solid preparation excipients are essential for formulating solid dosage forms such as tablets, capsules, and powders. This category is one of the largest applications, representing around 35% of the pharmaceutical excipients market. Solid preparation excipients include binders, disintegrants, fillers, and lubricants, which are necessary for ensuring uniformity, stability, and ease of processing. With the growing demand for oral dosage forms due to their convenience and cost-effectiveness, the solid preparation segment continues to be a major driver of the excipient market. The increasing prevalence of chronic conditions requiring long-term medication is further contributing to the demand for solid dosage forms.
- Semi-Solid Preparation Excipients: Semi-solid preparation excipients are used in the formulation of creams, gels, ointments, and other topical products. This segment accounts for approximately 15% of the pharmaceutical excipients market. These excipients include thickeners, emulsifiers, and stabilizers, which help achieve the desired texture, spreadability, and stability of semi-solid formulations. As the demand for topical treatments, such as dermatological and cosmetic products, increases, the need for semi-solid preparation excipients grows. The rise in skin-related conditions and advancements in cosmetic formulations are contributing to the expansion of this market segment, particularly in regions with high demand for over-the-counter skin care products.
- Liquid Preparation Excipients: Liquid preparation excipients are used in the formulation of liquid dosage forms such as syrups, injections, and oral liquids. This application segment holds around 10% of the global excipient market. Liquid preparation excipients serve as solubilizers, preservatives, and stabilizers to ensure the effective delivery of drugs in liquid form. The growing use of injectable drugs and liquid medicines, particularly in pediatric and geriatric populations, is boosting the demand for these excipients. With advancements in biologic drugs and liquid formulations, the demand for liquid preparation excipients is expected to continue growing, as they are essential for ensuring the stability and efficacy of liquid-based drugs.
- Other Excipients: The Other excipients category encompasses a diverse range of applications, including those used in advanced drug delivery systems, vaccines, and biologics. This segment represents approximately 10% of the pharmaceutical excipients market. Excipients used in this category include specialty ingredients like polymers, proteins, and lipids, which are crucial for the development of targeted and controlled-release formulations. The growing focus on personalized medicine, gene therapies, and vaccines is driving the demand for these specialized excipients. As pharmaceutical companies increasingly explore complex drug formulations, the need for these advanced excipients continues to rise, contributing to their expanding market share.
Regional Outlook
The pharmaceutical excipients market displays significant regional variations, each influenced by unique factors such as market maturity, demand for pharmaceuticals, and regulatory policies. North America holds a dominant market share of 35%, driven by its robust pharmaceutical production capabilities and high healthcare expenditure. Europe follows with a share of 25%, supported by well-established pharmaceutical infrastructure and stringent regulatory frameworks. The Asia-Pacific region, accounting for 20%, is experiencing rapid market expansion due to increasing manufacturing capabilities and a rising demand for generics. The Middle East & Africa region represents around 10% of the market, driven by improving healthcare infrastructure and growing pharmaceutical consumption.
North America
North America holds the largest share of the pharmaceutical excipients market, accounting for approximately 35%. This dominance is driven by the region's advanced pharmaceutical infrastructure, high demand for innovative drug formulations, and robust healthcare systems. The U.S. pharmaceutical sector is a significant contributor, with a focus on research and development of novel drugs, particularly in the biopharmaceutical sector. Additionally, the region's demand for excipients used in solid and liquid drug formulations continues to grow. With strong regulatory support and a high concentration of major pharmaceutical manufacturers, North America remains a key market for excipients.
Europe
Europe represents the second-largest market for pharmaceutical excipients, capturing around 25% of the global market share. The region benefits from a well-established pharmaceutical industry, with countries like Germany, the U.K., and Switzerland leading in excipient production. Regulatory frameworks in Europe are stringent, ensuring the quality and safety of excipients used in drug manufacturing. Furthermore, Europe's aging population and the growing prevalence of chronic diseases are driving the demand for more complex drug formulations, which in turn fuels the excipient market. The shift towards biologics and personalized medicines in Europe further increases the demand for specialized excipients.
Asia-Pacific
The Asia-Pacific region is experiencing the fastest growth in the pharmaceutical excipients market, with a projected increase of 25%. This growth is primarily attributed to the rising pharmaceutical manufacturing capabilities in countries like China and India. The expanding middle-class population in these countries is also driving demand for better healthcare solutions. Additionally, cost-effective production and the rising prevalence of chronic diseases are fueling the growth of the excipient market. As the region continues to improve its pharmaceutical infrastructure and regulatory standards, the Asia-Pacific market is expected to see significant advancements in excipient production, particularly for solid and liquid formulations.
Middle East & Africa
The Middle East & Africa region contributes around 5% to the global pharmaceutical excipients market. While this is a smaller share compared to other regions, the market is expanding rapidly due to improvements in healthcare systems, particularly in countries like the UAE and Saudi Arabia. Increased investments in healthcare infrastructure and the growing demand for pharmaceutical products, including generics, are expected to drive the excipient market. Additionally, with more pharmaceutical companies focusing on the region's potential, there is an increasing need for excipients that cater to the unique requirements of the Middle Eastern and African pharmaceutical industries.
List of Key Players in the Pharmaceutical Excipients Market
- DuPont (FMC)
- JRS Pharma
- BASF
- Lubrizol
- Ashland
- Croda International
- Roquette
- Shin-Etsu
- Evonik
- Associated British Foods
- Hnerkang
- Anhui Sunhere Pharmaceutical Excipients
- Chase Sun
Two top companies with the highest share in the pharmaceutical excipients market
- DuPont (FMC) - Holding approximately 18% of the global market share.
- BASF - Accounting for around 15% of the market share.
Investment Analysis and Opportunities
The pharmaceutical excipients market is witnessing significant investment opportunities, with key players looking to expand their footprint through mergers, acquisitions, and new product innovations. North America, accounting for approximately 35% of the market share, continues to attract substantial investments due to the strong pharmaceutical manufacturing sector and regulatory support. Emerging economies in the Asia-Pacific region, representing around 25% of the market, are also experiencing increased investments in excipient manufacturing due to rising demand for pharmaceutical products and improved manufacturing capabilities. Companies are investing in advanced technologies such as nanotechnology and 3D printing to develop excipients that offer better drug delivery and bioavailability. Additionally, there is a notable rise in investments aimed at improving the quality and functionality of excipients for biologics and personalized medicine.
New Product Development
New product development is a major focus within the pharmaceutical excipients market as companies strive to meet the evolving demands of the pharmaceutical industry. In 2023, DuPont introduced a new line of excipients for use in biologics and injectables, designed to improve solubility and stability. This innovation addresses the growing need for excipients that support the development of high-value biologic drugs. Similarly, BASF launched an innovative excipient designed for controlled-release formulations, aimed at improving the efficacy of medications that require long-term stability and consistent release profiles. With the increasing focus on personalized medicine, excipient manufacturers are also working on developing tailored solutions that can cater to the specific needs of individual patients. The growing demand for these specialized excipients has led companies to invest heavily in R&D, with 20% of the market share driven by excipient innovations for complex drug formulations.
Recent Developments by Manufacturers in Pharmaceutical Excipients Market
- DuPont introduced a new range of excipients in early 2024, specifically targeting the formulation of biologics, offering improved solubility and stabilization.
- BASF expanded its product portfolio in 2023 by introducing new excipient solutions for controlled-release oral dosage forms, catering to the increasing demand for more effective drug delivery systems.
- Ashland launched a new line of natural excipients in 2024, focusing on the increasing demand for plant-based and sustainable excipient solutions, responding to the growing eco-conscious market.
- Evonik in 2023 announced a partnership to develop advanced excipients aimed at enhancing the delivery of poorly water-soluble drugs, contributing to the growth of the oral drug delivery market.
- Roquette introduced a new excipient for liquid formulations in 2024, specifically targeting pediatric and geriatric patient populations, where taste-masking and ease of ingestion are key requirements.
Report Coverage of Pharmaceutical Excipients Market
The Pharmaceutical Excipients Market report provides an in-depth analysis of market dynamics, trends, growth drivers, and challenges faced by the industry. It covers excipient types such as cellulose and derivatives, starch and derivatives, inorganic salts, medicinal sucrose, and others, offering a comprehensive look at each segment’s share and growth potential. The report also analyzes various applications including formulation stability excipients, solid preparation excipients, semi-solid preparation excipients, liquid preparation excipients, and other specialized excipient categories. Key regions covered include North America, Europe, Asia-Pacific, and the Middle East & Africa, with detailed regional insights highlighting growth prospects and market share. The report examines key players in the industry such as DuPont, BASF, and Ashland, providing information on their strategies, new product developments, and recent market movements. The global market share distribution indicates North America’s leading position at 35%, followed by Europe at 25%, and the Asia-Pacific region at 20%.
Pharmaceutical Excipients Market Report Coverage
| REPORT COVERAGE | DETAILS | |
|---|---|---|
|
Market Size Value In |
USD 11.11 Billion in 2026 |
|
|
Market Size Value By |
USD 21.98 Billion by 2035 |
|
|
Growth Rate |
CAGR of 7.06% from 2026 - 2035 |
|
|
Forecast Period |
2026 - 2035 |
|
|
Base Year |
2025 |
|
|
Historical Data Available |
Yes |
|
|
Regional Scope |
Global |
|
|
Segments Covered |
By Type :
By Application :
|
|
|
To Understand the Detailed Market Report Scope & Segmentation 
Download FREE Sample
|
||
Frequently Asked Questions
-
What value is the Pharmaceutical Excipients Market expected to touch by 2035?
The global Pharmaceutical Excipients Market is expected to reach USD 21.98 Billion by 2035.
-
What CAGR is the Pharmaceutical Excipients Market expected to exhibit by 2035?
The Pharmaceutical Excipients Market is expected to exhibit a CAGR of 7.06% by 2035.
-
Who are the top players in the Pharmaceutical Excipients Market?
WACKER Chemie AG, Evonik Industries AG, Croda International, Air Liquide, Kerry Group, Innophous Holdings, DFE Pharma, Archer Daniels Midland Company, Roquette Feres, Ashland Global Holdings, DuPont, BASF SE, Associated British Foods, JRS Pharma, Lubrizol Corporation, Colorcon
-
What was the value of the Pharmaceutical Excipients Market in 2025?
In 2025, the Pharmaceutical Excipients Market value stood at USD 11.11 Billion.
Our Clients
